NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form-3? ...

NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." or the "Company") (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https ...

NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...

NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in StubHub Holdings, Inc. ("StubHub Holdings, Inc." or the "Company") (NYSE: STUB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of StubHub Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired StubHub common stock pursuant and/or traceable to the registratio ...

Core Viewpoint - DeFi Technologies is facing a class action lawsuit due to alleged securities fraud, impacting investors who suffered losses between May 12, 2025, and November 14, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that DeFi Technologies made false statements regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver for the company [2]. - It is alleged that the company understated the competition from other digital asset treasury companies, affecting its ability to execute its DeFi arbitrage strategy [2]. - As a result of these issues, DeFi Technologies is unlikely to meet its previously issued revenue guidance for the fiscal year 2025 [2]. - The defendants are accused of downplaying the negative impact of these issues on the company's business and financial results, leading to materially false and misleading public statements [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until January 30, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. for failing to disclose significant changes affecting its cash flow during its IPO period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired StubHub securities from September 14, 2025, to November 24, 2025, including shares from the September 2025 IPO [1]. - Investors have until January 23, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Operations - StubHub operates a global online marketplace for buying and selling tickets for live sports, music, and entertainment events [2]. Group 3: Allegations - The complaint alleges that StubHub's IPO Registration Statement did not disclose changes in payment timing to vendors, which adversely affected the company's free cash flow [3].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corp. on behalf of investors who purchased shares during the specified Class Period, alleging that the merger with Cedar Fair L.P. was misrepresented in terms of the company's financial and operational condition [1][3]. Group 1: Lawsuit Details - The lawsuit claims that the registration statement and prospectus related to the merger did not accurately reflect Six Flags' financial and operational challenges, particularly years of underinvestment that left its parks needing significant capital to remain competitive [3]. - Investors who acquired Six Flags securities during the Class Period have until January 5, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Stock Performance - On the closing date of the merger, July 1, 2024, Six Flags stock was trading above $55 per share, but it subsequently fell to as low as $20, representing a 64% loss in value [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [3]. - Investors have until February 9, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Integer Holdings Corporation designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. - The company had previously claimed strong sales growth and market position for its EP devices, which is now being challenged [4]. Group 3: Financial Performance - Integer lowered its 2025 sales guidance to a range of $1.840 billion to $1.854 billion, down from $1.850 billion to $1.876 billion, which is below analysts' expectations [6]. - The company anticipates poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026 [6]. - Following the announcement, Integer's stock price fell by $35.22 per share, a decline of over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [6][5].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 12, 2026, to request to lead the case, which is pending in the U.S. District Court for the Eastern District of Virginia [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Stride securities [2]. Group 2: Allegations Against Stride - Stride, an education technology company, allegedly inflated enrollment numbers by retaining "ghost students" and ignored compliance requirements, leading to poor customer experiences and higher withdrawal rates [3]. - The company claimed to be experiencing growth and strong demand, which is contradicted by the allegations of inflated enrollment figures and compliance failures [3]. Group 3: Stock Price Impact - On September 14, 2025, a report of the fraud allegations caused Stride's stock to drop by $18.60, or over 11%, from $158.36 to $139.76 per share [4]. - Following Stride's admission of poor customer experience on October 28, 2025, the stock plummeted by $83.48, or more than 54%, from $153.53 to $70.05 per share, with an estimated impact of 10,000-15,000 fewer enrollments [5].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Inspire Medical Systems develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Lawsuit Details - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Inspire stock, with the case pending in the U.S. District Court for the District of Minnesota [3]. - Investors have until January 5, 2026, to request to be appointed to lead the case [3]. Stock Performance and Issues - Inspire assured investors that it had taken necessary steps for the launch of Inspire V, but failed to prepare clinicians and payors, leading to significant delays and weak demand [5][6]. - On August 4, 2025, Inspire disclosed an "elongated timeframe" for the Inspire V launch and reduced its 2025 earnings per share guidance by over 80%, attributing this to undisclosed factors including incomplete training at implanting centers and poor demand due to excess inventory of older devices [7]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].